• DHSC permits use of antiviral medicines against influenza

    The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment of influenza at

    Read more
  • MHRA Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd)

    Class 4 Medicines Defect Information: Oxycodone Hydrochloride 10mg/ml oral solution (Lucis Pharma Ltd) Drug alert number: EL (22)A/49 Date issued: 29 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxycodone Hydrochloride 10mg/ml oral solution, PL 42176/0015 Batch Number Expiry Date Pack Size First

    Read more
  • Christmas Day 2022: Updating pharmacy opening hours on NHS Profile Manager

    NHS England has confirmed that all community pharmacy Directory of Service (DoS) and NHS website profiles will automatically be set to show as closed on Sunday 25th December 2022 (Christmas Day). It is important that your profile information is correct so that NHS staff, patients and the public can access accurate contact information, opening times

    Read more
  • Drug Tariff Watch – December 2022

    The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 December 2022. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. § Selected

    Read more
  • Mandatory workforce survey closes on Wednesday

    Community pharmacy contractors are reminded of the mandatory requirement to complete the 2022 Community Pharmacy Workforce Survey, managed by Health Education England (HEE), by Wednesday (30th November 2022). Completion of the survey is a mandatory requirement for all contractors. The NHS Business Services Authority (NHSBSA) sent an email to contractors on 6th October 2022 containing a link to

    Read more
  • Pharmacy Vision: Contractors and LPCs start to share views

    Work to develop a new vision and strategic options for community pharmacy is now well underway, being led by Nuffield Trust and The King’s Fund. Alongside a literature review and wider research being carried out by the two health policy think tanks, PSNC is running an open consultation which some contractors and LPCs have already

    Read more
  • November 2022 Price Concessions 3rd Update

    The Department of Health and Social Care (DHSC) has today (25/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 500mg capsules 15 £1.85 Amoxicillin 500mg capsules 21 £2.59 Omeprazole 20mg gastro-resistant capsules 28 £2.60 Prednisolone 5mg soluble tablets 30 £62.00 Pregabalin 25mg capsules 56 £1.69 The DHSC

    Read more
  • NHSmail changes: keeping your account active

    To increase the security of the NHSmail system, the NHSmail team will shortly be making changes to the system that will impact users. From 1st December 2022, personal NHSmail accounts which are not used for 30 days will be marked inactive and inactive accounts which are not activated within the following 30 days will be

    Read more
  • Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atorvastatin (Lipitor®) 20mg chewable tablets. MSN/2022/098 Tier 2 – medium impact Date of issue 24th November 2022 Atorvastatin (Lipitor®) 20mg chewable tablets are out of stock until late December 2022. Atorvastatin 20mg film-coated tablets and atorvastatin 20mg/5ml oral suspension remain available

    Read more
  • New SSP issued for Lipitor® 20mg chewable tablets

    In response to a significant ongoing disruption to the supply of Lipitor® 20mg chewable tablets , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 23 November 2022, SSP039 provides that for every Lipitor® 20mg chewable tablet originally prescribed, either one Atorvastatin 20mg tablet or the equivalent

    Read more